首页> 外文期刊>Urology >Microscopic invasion of perivesical fat by urothelial carcinoma: implications for prognosis and pathology practice.
【24h】

Microscopic invasion of perivesical fat by urothelial carcinoma: implications for prognosis and pathology practice.

机译:尿路上皮癌对镜下脂肪的微观侵袭:对预后和病理学实践的影响。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: To determine whether microscopic invasion of perivesical fat by urothelial carcinoma (stage pT3a) confers a different prognosis relative to deep muscle invasion (pT2b) and/or gross extravesical extension (pT3b) among patients with a given nodal status treated by cystectomy. METHODS: Cancer records for patients diagnosed with stage pT2b-pT3b bladder cancer from 1998-2006 were obtained from the SEER database (n = 2388). Pathologic substage (pT3a vs pT2b vs pT3b) was the primary covariate of interest. Other covariates included age, sex, race, grade, number of nodes examined, number of positive nodes, nodal stages, and radiotherapy. Cox regression model was used to estimate the covariate-adjusted effect of tumor substages on all-cause mortality. RESULTS: The risk of nodal metastases increased with increasing substage (pT2b = 20%, pT3a = 36%, pT3b = 48%, trend P <.001). Among patients with node-negative tumors, the adjusted hazard ratios for all-cause mortality were 1.68 (P <.001) for pT3a vs pT2b and 1.03 (P = .78) for pT3b vs pT3a tumors, whereas for node-positive disease, they were 1.42 (P = .009) for pT3a vs pT2b and 1.44 (P = .001) for pT3b vs pT3a tumors. CONCLUSIONS: Microscopic invasion of perivesical fat was associated with significantly inferior survival relative to pT2b disease of the same nodal status. For node-positive pT3 tumors, more advanced pathologic substage (pT3b vs pT3a) was also associated with decreased survival. Our findings support the current practice of pathologic distinction between pT2b and pT3a disease and substaging of extravesical tumors based on microscopic versus gross extravesical extension.
机译:目的:确定在膀胱切除术治疗的给定淋巴结状态的患者中,尿路上皮癌(pT3a期)镜下浸润性膀胱镜脂肪是否赋予相对于深部肌肉浸润(pT2b)和/或总膀胱外扩张(pT3b)的不同预后。方法:从SEER数据库(n = 2388)获得1998-2006年诊断为pT2b-pT3b阶段性膀胱癌的患者的癌症记录。病理亚阶段(pT3a vs pT2b vs pT3b)是主要的协变量。其他协变量包括年龄,性别,种族,等级,检查的淋巴结数目,阳性淋巴结数目,淋巴结分期和放疗。使用Cox回归模型来评估肿瘤亚阶段对全因死亡率的协变量调整效应。结果:淋巴结转移的风险随亚阶段的增加而增加(pT2b = 20%,pT3a = 36%,pT3b = 48%,趋势P <.001)。在淋巴结阴性肿瘤患者中,pT3a和pT2b的全因死亡率调整后的危险比分别为1.68(P <.001)和pT3b vs pT3a肿瘤的1.03(P = .78),而对于淋巴结阳性疾病, pT3a与pT2b的肿瘤分别为1.42(P = .009)和pT3b与pT3a的肿瘤分别为1.44(P = .001)。结论:相对于相同淋巴结状态的pT2b疾病,镜下脂肪浸润与镜下脂肪的存活率显着降低有关。对于淋巴结阳性的pT3肿瘤,更高级的病理亚阶段(pT3b与pT3a)也与生存期降低相关。我们的发现支持当前对pT2b和pT3a疾病进行病理学区分以及基于显微镜对大范围膀胱外扩张的膀胱外肿瘤亚分类的实践。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号